USNA Q1 2026 Earnings Call Summary

USANA Health Sciences, Inc. (Q1 2026 Earnings Call Summary)

1. Key Financial Results and Metrics

Net Sales: $204 million for Q1 2026, representing a 7% sequential growth, primarily driven by customer growth in China.
HYA Sales: $32 million in net sales with 186,000 active monthly subscribers, showing modest sequential improvement.
Rise Wellness Sales: $14 million, reflecting an impressive 143% sequential increase and over eight times the prior year's first quarter.
Full-Year Guidance: USANA reaffirmed its consolidated net sales guidance for 2026, projecting between $925 million and $1 billion.

2. Strategic Updates and Business Highlights

USANA is transitioning from a direct sales model to a diversified omni-channel health and wellness platform.
Key initiatives include:
- Compensation Plan: Enhancements to the brand partner compensation plan to boost distributor productivity and retention.
- Product Launches: Accelerating the rollout of new and upgraded products across all segments.
- Technology Modernization: Investments in IT infrastructure to improve customer experience and operational efficiencies.
HYA has expanded into Canada and the UK, and products are now available at Target, marking its entry into retail.
Rise Wellness has successfully launched Protein Pop Plus in Costco, contributing to significant sales growth.

3. Forward Guidance and Outlook

USANA expects omni-channel net sales to exceed 20% of total sales in 2026, up from 16% in 2025.
Continued investment in technology and product development is planned, funded through operational efficiencies.
The company remains optimistic about stabilizing its core nutritional business and scaling its omni-channel brands.

4. Bad News, Challenges, or Points of Concern

Customer Acquisition Costs: HYA is facing elevated customer acquisition costs due to disruptions in the Meta advertising environment, impacting SG&A expenses.
Market Conditions: While the macro environment in China is currently stable, potential future impacts from global events (e.g., the Iran conflict) remain uncertain.
Competitive Pressures: The evolving marketplace for Rise Wellness products is competitive, and the company must navigate these dynamics effectively.

5. Notable Q&A Insights

China Market: The macroeconomic environment in China appears stable, with no significant impacts from inflationary pressures observed yet.
Product Development: Over 20 new products are in development across various segments, focusing on women's and children's health.
HYA Performance: Initial sales in Canada have exceeded expectations, while the UK market is still in early stages but holds promise.
Retail Expansion: Rise Wellness has secured agreements with nine additional major U.S. retailers, indicating ongoing growth potential.

Overall, USANA's Q1 2026 results reflect a positive trajectory in sales and strategic initiatives, although challenges related to customer acquisition costs and competitive pressures remain. The company is committed to its transformation and growth strategy, with a clear focus on innovation and market expansion.

USNA — USANA Health Sciences, Inc.